Keywords: N-acetylcysteine, Fatty liver disease, Hepatic steatosis, Metabolic dysfunction, Metabolic profile, Clinical trial Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), is defined as fat accumulation in more than 5% of liver cells when other risk factors for fat accumulation, such as alcohol or drugs, have been ruled out
Cell death (CD) is essential for maintaining homeostasis and basic biological functions within tissues, and its changes are of great importance in disease pathology
Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus
Illustratively, in the mentioned laser-wound studies, human albumin solder supplemented with transforming growth factor (TGF)-1 only, but not with HB-EGF or bFGF, increased the early postoperative strength of laser-welded wounds (Poppas et al., 1996), even though the superpulsed CO 2 laser enhanced fibroblast replication and appeared to stimulate bFGF and inhibit TGF-1 secretion (Nowak et al., 2000)
